NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Awarded Final Judgment, Confirmation of $3M-Plus Arbitration Award
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, has announced that the United States District Court for the Eastern District of Pennsylvania ruled in favor of FSD Pharma and is granted its motion for entry of judgment against Dr. Raza Bokhari, the company’s former CEO. The decision awards FSD Pharma several awards, including $147,301.04 plus interest at a rate of 4% per annum from Nov. 9, 2022, until the date the judgment is satisfied; C$31,912.55 plus interest at a rate…







